These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26750518)

  • 1. Q-learning residual analysis: application to the effectiveness of sequences of antipsychotic medications for patients with schizophrenia.
    Ertefaie A; Shortreed S; Chakraborty B
    Stat Med; 2016 Jun; 35(13):2221-34. PubMed ID: 26750518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Q-learning: a data analysis method for constructing adaptive interventions.
    Nahum-Shani I; Qian M; Almirall D; Pelham WE; Gnagy B; Fabiano GA; Waxmonsky JG; Yu J; Murphy SA
    Psychol Methods; 2012 Dec; 17(4):478-94. PubMed ID: 23025434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Set-valued dynamic treatment regimes for competing outcomes.
    Laber EB; Lizotte DJ; Ferguson B
    Biometrics; 2014 Mar; 70(1):53-61. PubMed ID: 24400912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.
    Li Z
    Stat Med; 2017 Feb; 36(3):403-415. PubMed ID: 27646957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multiple imputation strategy for sequential multiple assignment randomized trials.
    Shortreed SM; Laber E; Scott Stroup T; Pineau J; Murphy SA
    Stat Med; 2014 Oct; 33(24):4202-14. PubMed ID: 24919867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.
    Li X; Guo X; Fan X; Feng T; Wang C; Yao Z; Xu X; Chen Z; Wang H; Xie S; He J; Zhuo K; Xiang Q; Cen H; Wang J; Smith RC; Jin H; Keshavan MS; Marder SR; Davis JM; Jiang K; Xu Y; Liu D
    Schizophr Res; 2021 Apr; 230():87-94. PubMed ID: 33279374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should antipsychotic medications for schizophrenia be given for a lifetime? Replication of a naturalistic, long-term, follow-up study of antipsychotic treatment.
    Glick ID; Zamora D; Kamis D; Davis JM
    CNS Spectr; 2019 Oct; 24(5):557-563. PubMed ID: 30777584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic treatment regimes for managing chronic health conditions: a statistical perspective.
    Chakraborty B
    Am J Public Health; 2011 Jan; 101(1):40-5. PubMed ID: 21088260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.
    Bervoets C; Morrens M; Vansteelandt K; Kok F; de Patoul A; Halkin V; Pitsi D; Constant E; Peuskens J; Sabbe B
    CNS Drugs; 2012 Nov; 26(11):975-82. PubMed ID: 23018547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) study: a novel comparative trial of once-monthly paliperidone palmitate versus daily oral antipsychotic treatment for delaying time to treatment failure in persons with schizophrenia.
    Alphs L; Mao L; Rodriguez SC; Hulihan J; Starr HL
    J Clin Psychiatry; 2014 Dec; 75(12):1388-93. PubMed ID: 25375367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia.
    Basu A; Benson C; Alphs L
    J Manag Care Spec Pharm; 2018 Aug; 24(8):759-768. PubMed ID: 30058979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic Treatment Regimes.
    Chakraborty B; Murphy SA
    Annu Rev Stat Appl; 2014; 1():447-464. PubMed ID: 25401119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating optimal shared-parameter dynamic regimens with application to a multistage depression clinical trial.
    Chakraborty B; Ghosh P; Moodie EE; Rush AJ
    Biometrics; 2016 Sep; 72(3):865-76. PubMed ID: 26890628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions.
    Zhang B; Tsiatis AA; Laber EB; Davidian M
    Biometrika; 2013; 100(3):. PubMed ID: 24302771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactive Q-learning for Quantiles.
    Linn KA; Laber EB; Stefanski LA
    J Am Stat Assoc; 2017; 112(518):638-649. PubMed ID: 28890584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.
    Kirson NY; Weiden PJ; Yermakov S; Huang W; Samuelson T; Offord SJ; Greenberg PE; Wong BJ
    J Clin Psychiatry; 2013 Jun; 74(6):568-75. PubMed ID: 23842008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.
    Zhao YQ; Zeng D; Laber EB; Kosorok MR
    J Am Stat Assoc; 2015; 110(510):583-598. PubMed ID: 26236062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constructing dynamic treatment regimes with shared parameters for censored data.
    Zhao YQ; Zhu R; Chen G; Zheng Y
    Stat Med; 2020 Apr; 39(9):1250-1263. PubMed ID: 31951041
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.